IMS Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $364K | Buy |
1,290
+1
| +0.1% | +$290 | 0.17% | 97 |
|
|
2025
Q2 | $360K | Sell |
1,289
-298
| -19% | -$84.4K | 0.17% | 99 |
|
|
2025
Q1 | $495K | Sell |
1,587
-3,705
| -70% | -$1.09M | 0.25% | 81 |
|
|
2024
Q4 | $1.38M | Sell |
5,292
-9
| -0.2% | -$2.67K | 0.64% | 43 |
|
|
2024
Q3 | $1.71M | Sell |
5,301
-34
| -0.6% | -$11.1K | 0.77% | 39 |
|
|
2024
Q2 | $1.75M | Sell |
5,335
-599
| -10% | -$176K | 0.82% | 36 |
|
|
2024
Q1 | $1.69M | Buy |
5,934
+576
| +11% | +$169K | 0.78% | 40 |
|
|
2023
Q4 | $1.54M | Buy |
5,358
+1,501
| +39% | +$409K | 0.76% | 40 |
|
|
2023
Q3 | $1.04M | Hold |
3,857
| – | – | 0.62% | 44 |
|
|
2023
Q2 | $856K | Buy |
3,857
+1,535
| +66% | +$356K | 0.48% | 55 |
|
|
2023
Q1 | $561K | Hold |
2,322
| – | – | 0.33% | 76 |
|
|
2022
Q4 | $610K | Hold |
2,322
| – | – | 0.39% | 73 |
|
|
2022
Q3 | $523K | Sell |
2,322
-31
| -1% | -$7.51K | 0.36% | 78 |
|
|
2022
Q2 | $572K | Buy |
2,353
+57
| +2% | +$14K | 0.37% | 74 |
|
|
2022
Q1 | $555K | Sell |
2,296
-50
| -2% | -$11.5K | 0.29% | 84 |
|
|
2021
Q4 | $528K | Buy |
2,346
+318
| +16% | +$67.1K | 0.27% | 78 |
|
|
2021
Q3 | $431K | Buy |
2,028
+275
| +16% | +$63.3K | 0.25% | 82 |
|
|
2021
Q2 | $427K | Sell |
1,753
-1,245
| -42% | -$306K | 0.25% | 80 |
|
|
2021
Q1 | $746K | Buy |
2,998
+1,125
| +60% | +$268K | 0.47% | 57 |
|
|
2020
Q4 | $431K | Sell |
1,873
-84
| -4% | -$19.4K | 0.27% | 76 |
|
|
2020
Q3 | $497K | Hold |
1,957
| – | – | 0.36% | 72 |
|
|
2020
Q2 | $462K | Sell |
1,957
-790
| -29% | -$180K | 0.36% | 74 |
|
|
2020
Q1 | $557K | Sell |
2,747
-1,435
| -34% | -$313K | 0.57% | 57 |
|
|
2019
Q4 | $1.01M | Buy |
4,182
+25
| +0.6% | +$5.51K | 0.69% | 35 |
|
|
2019
Q3 | $804K | Buy |
4,157
+2,475
| +147% | +$475K | 0.61% | 41 |
|
|
2019
Q2 | $310K | Hold |
1,682
| – | – | 0.23% | 92 |
|
|
2019
Q1 | $320K | Hold |
1,682
| – | – | 0.26% | 88 |
|
|
2018
Q4 | $327K | Hold |
1,682
| – | – | 0.31% | 84 |
|
|
2018
Q3 | $349K | Sell |
1,682
-21
| -1% | -$4.14K | 0.24% | 84 |
|
|
2018
Q2 | $314K | Sell |
1,703
-180
| -10% | -$31.8K | 0.2% | 103 |
|
|
2018
Q1 | $327K | Hold |
1,883
| – | – | 0.2% | 106 |
|
|
2017
Q4 | $327K | Buy |
1,883
+209
| +12% | +$37K | 0.2% | 106 |
|
|
2017
Q3 | $312K | Buy |
1,674
+308
| +23% | +$54.6K | 0.2% | 109 |
|
|
2017
Q2 | $235K | Buy |
1,366
+66
| +5% | +$10.7K | 0.22% | 122 |
|
|
2017
Q1 | $213K | Buy |
+1,300
| New | +$216K | 0.21% | 119 |
|
|
2016
Q4 | – | Sell |
-1,300
| Closed | -$217K | – | 140 |
|
|
2016
Q3 | $217K | Buy |
+1,300
| New | +$220K | 0.25% | 110 |
|
|
2014
Q4 | – | Sell |
-2,336
| Closed | -$328K | – | 153 |
|
|
2014
Q3 | $328K | Hold |
2,336
| – | – | 0.38% | 99 |
|
|
2014
Q2 | $277K | Buy |
2,336
+620
| +36% | +$71.8K | 0.3% | 112 |
|
|
2014
Q1 | $212K | Buy |
+1,716
| New | +$208K | 0.25% | 128 |
|
Other funds holding AMGN
IMS Capital Management's AMGN Position: Q3 2025 in Review
IMS Capital Management increased its Amgen (AMGN) stake by 0.08% in Q3 2025, buying an estimated $290 and bringing the position to 1,290 shares worth $364K. The position accounts for 0.17% of the portfolio, ranked #97.
IMS Capital Management first reported a position in AMGN in Q1 2014 and has held it in 39 quarters since. The position peaked at $1.75M in Q2 2024. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- IMS Capital Management held 1,290 shares of Amgen worth $364K as of Q3 2025.
- IMS Capital Management bought 1 Amgen share in Q3 2025, an estimated $290.
- Amgen made up 0.17% of IMS Capital Management's portfolio in Q3 2025, its #97 holding.
- IMS Capital Management first reported a position in Amgen in Q1 2014 and has held it in 39 quarters since.
- IMS Capital Management's Amgen position peaked at $1.75M in Q2 2024.
- 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on IMS Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.